News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
857,084 Results
Type
Article (87166)
Company Profile (705)
Press Release (769190)
Multimedia
Podcasts (161)
Webinars (24)
Section
Business (232951)
Career Advice (4136)
Deals (39778)
Drug Delivery (132)
Drug Development (91179)
Employer Resources (200)
FDA (18238)
Job Trends (17383)
News (397133)
Policy (39880)
Tag
Academia (3002)
Academic (2)
Accelerated approval (16)
Adcomms (33)
Allergies (112)
Alliances (56979)
ALS (130)
Alzheimer's disease (1637)
Antibody-drug conjugate (ADC) (203)
Approvals (18222)
Artificial intelligence (441)
Autoimmune disease (41)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (145)
Biotechnology (483)
Bladder cancer (113)
Brain cancer (45)
Breast cancer (426)
Cancer (3412)
Cardiovascular disease (294)
Career advice (3549)
Career pathing (35)
CAR-T (224)
CDC (44)
Cell therapy (614)
Cervical cancer (28)
Clinical research (74765)
Collaboration (1235)
Company closure (4)
Compensation (822)
Complete response letters (45)
COVID-19 (2933)
CRISPR (74)
C-suite (468)
Cystic fibrosis (128)
Data (3538)
Decentralized trials (2)
Denatured (57)
Depression (90)
Diabetes (404)
Diagnostics (7030)
Digital health (28)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (208)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (176)
Earnings (98612)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (132200)
Executive appointments (945)
FDA (20397)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1100)
Gene editing (159)
Generative AI (43)
Gene therapy (486)
GLP-1 (980)
Government (5333)
Grass and pollen (7)
Guidances (330)
Healthcare (20933)
HIV (47)
Huntington's disease (32)
IgA nephropathy (51)
Immunology and inflammation (204)
Immuno-oncology (17)
Indications (44)
Infectious disease (3145)
Inflammatory bowel disease (175)
Inflation Reduction Act (13)
Influenza (84)
Intellectual property (153)
Interviews (814)
IPO (17919)
IRA (59)
Job creations (5195)
Job search strategy (2863)
Kidney cancer (15)
Labor market (67)
Layoffs (617)
Leadership (30)
Legal (10143)
Liver cancer (88)
Longevity (12)
Lung cancer (479)
Lymphoma (244)
Machine learning (17)
Management (65)
Manufacturing (531)
MASH (114)
Medical device (14806)
Medtech (14821)
Mergers & acquisitions (22659)
Metabolic disorders (1039)
Multiple sclerosis (110)
NASH (23)
Neurodegenerative disease (175)
Neuropsychiatric disorders (49)
Neuroscience (2488)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (54)
Obesity (524)
Opinion (302)
Ovarian cancer (111)
Pain (141)
Pancreatic cancer (140)
Parkinson's disease (211)
Partnered (27)
Patents (371)
Patient recruitment (239)
Peanut (56)
People (65978)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23056)
Phase II (32458)
Phase III (24446)
Pipeline (2365)
Policy (274)
Postmarket research (3554)
Preclinical (10405)
Press Release (72)
Prostate cancer (166)
Psychedelics (48)
Radiopharmaceuticals (281)
Rare diseases (583)
Real estate (7409)
Recruiting (76)
Regulatory (27577)
Reports (64)
Research institute (2670)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (14)
RSV (62)
Schizophrenia (113)
Series A (181)
Series B (133)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4314)
State (2)
Stomach cancer (17)
Supply chain (90)
Tariffs (81)
The Weekly (102)
Vaccines (991)
Venture capital (63)
Weight loss (360)
Women's health (54)
Worklife (20)
Date
Today (227)
Last 7 days (606)
Last 30 days (2746)
Last 365 days (34141)
2025 (22623)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (75)
Alaska (7)
Arizona (290)
Arkansas (14)
Asia (50744)
Australia (8910)
California (8680)
Canada (2638)
China (809)
Colorado (368)
Connecticut (385)
Delaware (235)
Europe (116502)
Florida (1291)
Georgia (298)
Hawaii (3)
Idaho (67)
Illinois (778)
India (43)
Indiana (419)
Iowa (19)
Japan (260)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1194)
Massachusetts (6577)
Michigan (293)
Minnesota (533)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (99)
New Hampshire (75)
New Jersey (2394)
New Mexico (31)
New York (2373)
North Carolina (1334)
North Dakota (10)
Northern California (3851)
Ohio (276)
Oklahoma (18)
Oregon (49)
Pennsylvania (1832)
Puerto Rico (18)
Rhode Island (43)
South America (1654)
South Carolina (44)
South Dakota (1)
Southern California (3269)
Tennessee (138)
Texas (1351)
United States (32353)
Utah (260)
Virginia (234)
Washington D.C. (82)
Washington State (744)
West Virginia (4)
Wisconsin (90)
There are 857,084 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves’ Disease Patients
September 4, 2025
·
7 min read
Press Releases
Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves’ Disease Patients
September 4, 2025
·
11 min read
Press Releases
Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy
September 4, 2025
·
4 min read
Press Releases
Corstasis Therapeutics Announces Allowance of a New Patent and Development Updates for Subcutaneous Programs RSQ-786 and RSQ-789
September 4, 2025
·
2 min read
Press Releases
Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2
September 4, 2025
·
4 min read
Press Releases
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
September 4, 2025
·
5 min read
Press Releases
Longeveron® Announces Key Leadership Updates
September 4, 2025
·
9 min read
Press Releases
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
September 4, 2025
·
3 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 3, 2025
September 4, 2025
·
1 min read
Press Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - September 3, 2025
September 4, 2025
·
2 min read
1 of 85,709
Next
